HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $153,666 | -4.6% | 216,431 | 0.0% | 0.00% | – |
Q1 2023 | $161,067 | +102490.4% | 216,431 | 0.0% | 0.00% | – |
Q4 2022 | $157 | -99.9% | 216,431 | -5.4% | 0.00% | – |
Q3 2022 | $221,000 | -49.3% | 228,734 | 0.0% | 0.00% | – |
Q2 2022 | $436,000 | -77.9% | 228,734 | -42.4% | 0.00% | – |
Q1 2022 | $1,974,000 | -37.4% | 397,191 | -4.9% | 0.00% | – |
Q4 2021 | $3,152,000 | +5.0% | 417,567 | +9.8% | 0.00% | – |
Q3 2021 | $3,003,000 | -38.5% | 380,213 | +8.0% | 0.00% | -100.0% |
Q2 2021 | $4,881,000 | -21.0% | 351,962 | +19.2% | 0.00% | 0.0% |
Q1 2021 | $6,177,000 | +103.3% | 295,274 | +61.4% | 0.00% | 0.0% |
Q4 2020 | $3,038,000 | +14.2% | 182,941 | +16.8% | 0.00% | 0.0% |
Q3 2020 | $2,660,000 | +22.6% | 156,564 | +19.8% | 0.00% | – |
Q2 2020 | $2,169,000 | +88.3% | 130,679 | +31.3% | 0.00% | – |
Q1 2020 | $1,152,000 | -55.5% | 99,531 | -43.1% | 0.00% | – |
Q4 2019 | $2,586,000 | +366.8% | 174,854 | +330.4% | 0.00% | – |
Q3 2019 | $554,000 | +21.2% | 40,628 | +15.6% | 0.00% | – |
Q2 2019 | $457,000 | +315.5% | 35,154 | +200.2% | 0.00% | – |
Q1 2019 | $110,000 | – | 11,709 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |